CEFEPIME (Renapime®)

Clinical Indication

for blood stream infections caused by organisms that commonly produce AmpC but that do not express ESBL. Severe infections with Pseudomonas areruginosa with OprD mediated Meropenem resistance.

Date of classification

January 2020


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.